Leidos
LDOS
$126.82
-0.70%
Leidos Holdings, Inc. is a technology, engineering, and science company providing services and solutions primarily to U.S. government agencies in the defense, intelligence, civil, and health sectors. The company is a major player in the government IT services and defense contracting industry, operating through segments including National Security & Digital, Health & Civil, and Defense Systems. The current investor narrative is dominated by a significant stock price decline following a Q4 2025 earnings report that, despite record profits, missed revenue expectations and provided cautious guidance, overshadowed by concerns over potential government budget disruptions and competitive threats from innovative private contractors in areas like autonomous systems.…
LDOS
Leidos
$126.82
Related headlines
Investment Opinion: Should I buy LDOS Today?
Rating: HOLD. The core thesis is that while Leidos is fundamentally cheap, the severe negative momentum and unclear trajectory of revenue and margins warrant caution, making it a 'show me' story rather than a clear buy.
Supporting this Hold rating are four key data points: 1) The compellingly low forward P/E of 9.7x, 2) The strong TTM FCF generation of $1.63B supporting financial health, 3) The manageable debt-to-equity ratio of 1.21, and 4) The stock's deeply oversold condition at just 5.4% above its 52-week low. However, these are counterbalanced by the 3.6% YoY revenue decline and the alarming gross margin compression from 18.4% to 16.0% quarter-over-quarter.
The two biggest risks invalidating a potential upgrade are sustained revenue contraction and further margin erosion. This Hold would upgrade to a Buy if the company demonstrates revenue stabilization and gross margins recover above 17% in the next quarter, confirming the sell-off was an overreaction. It would downgrade to a Sell if revenue decline accelerates beyond 5% YoY or if the stock breaks decisively below the $121.20 support level. Relative to its own history and sector, the stock is undervalued on earnings but fairly valued given the elevated fundamental risks.
Sign up to view all
LDOS 12-Month Price Forecast
The investment case for LDOS is a classic battle between value and momentum. The valuation is undeniably cheap, and the company's financial backbone remains strong due to substantial free cash flow. However, the severe price breakdown is justified by deteriorating fundamentals—declining revenue and collapsing margins. The neutral stance reflects the high uncertainty around whether these are transient issues or a permanent downshift. Confidence is medium because the next one or two earnings reports will be decisive. The stance would upgrade to bullish on evidence of margin stabilization and a technical recovery above $150; it would turn bearish on a breakdown below $121 or another significant guidance cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Leidos's 12-month outlook, with a consensus price target around $164.87 and implied upside of +30.0% versus the current price.
Average Target
$164.87
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$101 - $165
Analyst target range
Insufficient analyst coverage data is available to provide a detailed consensus view. The provided data includes institutional rating actions but lacks the critical consensus price targets, number of analysts, and buy/hold/sell distribution required for a full analysis. The available institutional ratings show a mix of 'Hold/Neutral' and 'Buy/Outperform' actions from firms like Stifel, Baird, RBC Capital, UBS, and Citigroup in early 2026, with Stifel downgrading from Buy to Hold in January. The absence of a clear consensus target and limited coverage depth is typical for a mid-cap defense contractor and can lead to higher volatility and less efficient price discovery, as the stock is more susceptible to sentiment shifts based on single earnings reports or news events rather than a broad analyst following.
Bulls vs Bears: LDOS Investment Factors
The evidence currently favors the bear case, as concrete negative fundamentals—revenue decline and margin compression—have triggered a severe and sustained technical breakdown. However, the magnitude of the sell-off has pushed valuation to deeply distressed levels, creating a sharp tension between deteriorating near-term fundamentals and extreme undervaluation. The single most important factor in the investment debate is whether the Q4 revenue miss and margin pressure represent a temporary execution issue or the beginning of a sustained competitive and operational decline. If the former, the current price is a compelling entry point; if the latter, the low multiples are a value trap.
Bullish
- Deeply Undervalued Forward P/E: The forward P/E of 9.7x is exceptionally low, trading at a significant discount to the trailing P/E of 16.7x. This suggests the market has priced in a severe earnings decline, creating a potential value trap or a major opportunity if earnings stabilize.
- Strong Free Cash Flow Generation: The company generates robust free cash flow, with TTM FCF of $1.63 billion. This provides a solid financial foundation, supports the dividend (yield ~0.87%), and offers flexibility for share buybacks or debt reduction despite revenue headwinds.
- Oversold Technical Condition: The stock is down 33.1% over six months and trades at $127.80, just 5.4% above its 52-week low of $121.20. This extreme sell-off, with a relative strength of -43.8 vs. the S&P 500 over six months, indicates panic selling that may have overcorrected fundamentals.
- Manageable Leverage & Liquidity: The debt-to-equity ratio of 1.21 and current ratio of 1.70 indicate a balanced capital structure and sufficient short-term liquidity. This financial stability reduces bankruptcy risk during a cyclical downturn in government contracting.
Bearish
- Severe Revenue Contraction & Miss: Q4 2025 revenue of $4.21B declined 3.6% YoY and missed expectations, following a sequential drop from Q3's $4.47B. This deceleration signals fundamental headwinds in contract wins or execution, directly contradicting growth narratives.
- Significant Margin Compression: Gross margin collapsed to 16.0% in Q4 2025 from 18.4% in Q3, indicating severe cost pressure or unfavorable contract mix. This erosion of profitability, if sustained, undermines the earnings rebound priced into the low forward P/E.
- Catastrophic Price & Momentum Breakdown: The stock has fallen 27.0% in three months and 12.4% in one month, drastically underperforming a rising market. This accelerating negative momentum, with a max drawdown of -38.3%, reflects a fundamental loss of investor confidence, not just a technical correction.
- Competitive Disruption & Guidance Risk: Recent news highlights disruptive threats from agile private contractors like Saronic in autonomous systems. Combined with cautious company guidance and potential government budget disruptions, these factors create a cloudy long-term outlook that justifies a valuation discount.
LDOS Technical Analysis
The prevailing price trend is a pronounced and sustained downtrend, with the stock down 13.4% over the past year and a severe 33.1% decline over the last six months. The current price of $127.80 sits near the bottom of its 52-week range, trading at approximately 62% of the range from a low of $121.20 to a high of $205.77, indicating the stock is deeply oversold and potentially presenting a value opportunity, though it remains in a clear bearish phase. Recent momentum shows severe acceleration to the downside, with the stock down 12.4% over the past month and 27.0% over the past three months, far underperforming the S&P 500, which gained 6.3% and 10.3% over the same periods, respectively. This sharp negative momentum, diverging from a broader market rally, signals intense company-specific selling pressure and a lack of near-term catalysts. Key technical levels are clear, with immediate support at the 52-week low of $121.20 and major resistance at the 52-week high of $205.77. A breakdown below $121.20 could trigger further capitulation, while a recovery above the $150 level is needed to suggest stabilization. The stock's beta of 0.57 indicates it has been significantly less volatile than the market, but its recent price action shows it is experiencing idiosyncratic, high-magnitude downside volatility.
Beta
0.57
0.57x market volatility
Max Drawdown
-38.3%
Largest decline past year
52-Week Range
$121-$206
Price range past year
Annual Return
-10.5%
Cumulative gain past year
| Period | LDOS Return | S&P 500 |
|---|---|---|
| 1m | -15.0% | +5.4% |
| 3m | -28.2% | +10.9% |
| 6m | -34.1% | +11.0% |
| 1y | -10.5% | +28.1% |
| ytd | -30.9% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
LDOS Fundamental Analysis
Leidos's revenue trajectory shows signs of deceleration and contraction, with Q4 2025 revenue of $4.21 billion representing a 3.6% year-over-year decline. The multi-quarter trend reveals a sequential drop from $4.47 billion in Q3 2025, indicating potential headwinds in contract timing or execution. Segment data highlights that National Security Solutions is the largest contributor at $5.02 billion, but the overall trend suggests growth challenges across the portfolio. The company remains profitable, posting Q4 2025 net income of $335 million, translating to a net margin of 7.96%. However, profitability metrics show pressure, as the gross margin of 16.0% in Q4 was down from 18.4% in the prior quarter, indicating margin compression. The full-year trend shows net income has been positive but volatile, with a trailing twelve-month free cash flow of $1.63 billion providing a solid foundation. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.21, which is manageable for a government contractor. The current ratio of 1.70 indicates sufficient short-term liquidity. Strong free cash flow generation, evidenced by the $1.63 billion TTM figure, supports the dividend and provides financial flexibility, though the recent revenue decline raises questions about future cash flow sustainability.
Quarterly Revenue
$4.2B
2026-01
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.16%
Latest Quarter
Free Cash Flow
$1.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is LDOS Overvalued?
Given a positive net income, the primary valuation metric is the P/E ratio. The trailing P/E stands at 16.7x, while the forward P/E is significantly lower at 9.7x, indicating the market expects a substantial earnings recovery. This large gap suggests the current price embeds pessimistic near-term expectations, with the forward multiple pricing in a significant earnings rebound. Compared to the broader technology services sector, Leidos's trailing P/E of 16.7x appears reasonable, though a direct industry average is not provided in the data. The more compelling story is the forward P/E discount, which may reflect concerns over the recent revenue miss and guidance. Historically, the stock's own valuation has compressed dramatically; its current trailing P/E of 16.7x is near the lower end of its observable historical range, which has seen multiples as high as 21.5x in early 2022. Trading near historical lows suggests the market is pricing in fundamental deterioration or a lowered growth profile, presenting a potential value opportunity if the company can stabilize its operations.
PE
16.7x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -8x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on the sustainability of Leidos's profitability and cash flow in the face of declining revenue. The 3.6% YoY revenue drop in Q4 2025, coupled with a 240 basis point sequential contraction in gross margin to 16.0%, indicates potential structural issues in contract pricing or cost management. While strong TTM FCF of $1.63B provides a buffer, a continuation of these trends would pressure dividends and leverage, with the debt-to-equity ratio of 1.21 becoming more burdensome if EBITDA declines.
Market & Competitive Risks are heightened by the stock's valuation compression and emerging disruptive threats. Trading at a forward P/E of 9.7x, the market is pricing in significant earnings risk, leaving little room for further disappointment. Externally, news of innovative private contractors like Saronic securing funding for autonomous naval systems poses a long-term threat to Leidos's defense franchise. Furthermore, the stock's low beta of 0.57 has not protected it from company-specific selling, indicating high idiosyncratic risk tied to government budget cycles and contract awards.
The Worst-Case Scenario involves a continuation of the current negative momentum fueled by another earnings miss, leading to a dividend cut or guidance withdrawal. This could trigger a breakdown below the key $121.20 support level, revisiting the stock's maximum drawdown of -38.3%. In this adverse scenario, the stock could fall an additional 20-25% from the current $127.80, targeting a range of $95-$102, as investor confidence completely evaporates and the low P/E multiple expands due to perceived heightened risk.
FAQ
The key risks are, in order of severity: 1) Operational Risk: Continued revenue decline and margin compression, as evidenced by the -3.6% YoY revenue growth and 240 bps QoQ gross margin drop to 16.0%. 2) Competitive Risk: Disruption from agile private contractors in high-growth areas like autonomous systems, threatening long-term market share. 3) Market Risk: The stock remains in a severe downtrend with a -33.1% six-month loss, indicating broken momentum and potential for further technical selling. 4) Macro/Political Risk: Dependence on U.S. government budgets exposes it to spending delays or cuts, impacting contract funding and new awards.
The 12-month forecast is bifurcated, with a base case target of $135-$155 (55% probability), a bull case of $170-$190 (25% probability), and a bear case of $105-$125 (20% probability). The base case, which is most likely, assumes the company stabilizes its operations without a quick return to growth, leading to a slow valuation recovery from deeply oversold levels. The forecast hinges almost entirely on the company's ability to halt the revenue decline and stop the margin erosion in the coming quarters. The wide range reflects the high uncertainty following the stock's dramatic collapse.
LDOS is fundamentally undervalued based on traditional earnings metrics. Its forward P/E of 9.7x is exceptionally low and represents a steep discount to its trailing P/E of 16.7x, implying the market expects a sharp earnings decline. The Price/Sales ratio of 1.41 also suggests a reasonable valuation for a government services contractor. However, this undervaluation is justified by the market's assessment of elevated risks, including revenue contraction and competitive threats. The valuation implies the market expects continued fundamental deterioration, not a recovery.
LDOS presents a high-risk, high-potential-reward opportunity that is not suitable for all investors. For a deep-value, contrarian investor willing to look past severe negative momentum, the forward P/E of 9.7x and strong FCF generation could make it a good speculative buy. However, given the 3.6% revenue decline and significant margin compression, it is not a good buy for growth investors or those seeking stability. The current price near 52-week lows suggests much of the bad news is priced in, but further deterioration could lead to more losses.
LDOS is unsuitable for short-term trading due to its severe negative momentum and high company-specific volatility despite a low beta of 0.57. It is a candidate only for long-term investors with a minimum horizon of 2-3 years who are betting on a fundamental turnaround. The company's stable dividend (0.87% yield) and strong free cash flow support a long-term income-oriented thesis, but the current operational headwinds mean investors must be patient. A recovery to fair value will be a multi-quarter process, requiring evidence of sustained operational improvement.